Latest Asx News

TrivarX has secured key approvals and begun recruiting for its innovative mental health screening trial in US veterans, while also launching a wearable tech pilot with a Major League Baseball academy in the Dominican Republic.

Volt Group reported a 15% decline in Q2 FY25 revenue due to customer order timing delays but secured new Wescone orders pointing to a strong Q3 recovery. Meanwhile, EcoQuip and ATEN projects advanced with promising demonstrations and feasibility studies.

Rokeby Resources has completed its acquisition of Stunalara Metals, securing promising gold-copper-antimony tenements, and commenced a maiden drilling campaign at the Hurricane Project in Queensland.

Cluey Ltd has reported its first-ever positive quarterly operating cash flow, marking a key financial milestone and signaling a strategic shift towards AI-led innovation and sustainable growth.

Dotz Nano has partnered with CarbonCapture Inc. to scale its high-performance direct air capture sorbent, while raising AU$1.2 million to fund its DotzEarth project amid ongoing funding timing challenges.

Brightstar Resources has delivered a strong Definitive Feasibility Study for its Laverton and Menzies Gold Projects, targeting over 338,000 ounces of gold with promising financial returns, while ramping up underground mining operations and securing $50 million in capital.

Blue Star Helium has raised A$4.5 million through a strategic institutional placement to fund the final stages of its Galactica helium project, aiming for production by late 2025.

American Rare Earths Limited reports strong progress at its Halleck Creek Rare Earths Project, highlighted by exceptional sampling results, key permitting milestones, and a $15 million equity raise to fund development.

Cosmo Metals has completed its acquisition of the Bingara and Nundle projects in NSW, revealing extensive historic workings and high-grade targets ahead of maiden drilling. A recent $2 million placement strengthens its exploration push.

AMCIL Limited reported a net profit of $6.7 million for FY2025, down from $7.5 million the previous year, and announced a fully franked total dividend of 6.5 cents per share, boosted by a special capital gains payout.

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.

Po Valley Energy reports steady gas production from its Podere Maiar-1 field and progresses permitting for new wells in Italy, supported by robust cash reserves and ongoing stakeholder engagement.